Artelo Biosciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

LEASE (Tables)

LEASE (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of operating lease right-of use assets and lease information

		Years ended
		December 31,
		2025				2024

Lease cost
Operating lease cost		$	35			$	32

Other information
Cash paid for operating cash flows from operating leases		$	35			$	30
Right-of-use assets obtained in exchange for new operating lease liability		$	-			$	111

Weighted-average remaining lease term — operating leases (year)			1.58				2.58
Weighted-average discount rate — operating leases			7.50%				7.50%

Schedule of operating lease liabilities future minimum lease payments

		Total
Year Ended December 31,
2026		$	43
2027			30
2028			-
2029			-
Thereafter			-
			73
Less: Imputed interest			(4	)
Operating lease liabilities			69

Operating lease liability - current			40
Operating lease liability - non-current		$	29